These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2489042)

  • 1. SP-40,40 is an inhibitor of C5b-6-initiated haemolysis.
    Murphy BF; Saunders JR; O'Bryan MK; Kirszbaum L; Walker ID; d'Apice AJ
    Int Immunol; 1989; 1(5):551-4. PubMed ID: 2489042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of SP-40,40 into the soluble membrane attack complex (SMAC, SC5b-9) of complement.
    Choi NH; Nakano Y; Tobe T; Mazda T; Tomita M
    Int Immunol; 1990; 2(5):413-7. PubMed ID: 2150757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.
    Bhakdi S; Käflein R; Halstensen TS; Hugo F; Preissner KT; Mollnes TE
    Clin Exp Immunol; 1988 Dec; 74(3):459-64. PubMed ID: 2466593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis.
    Murphy BF; Kirszbaum L; Walker ID; d'Apice AJ
    J Clin Invest; 1988 Jun; 81(6):1858-64. PubMed ID: 2454950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A serum protein SP40,40 modulates the formation of membrane attack complex of complement on erythrocytes.
    Choi NH; Mazda T; Tomita M
    Mol Immunol; 1989 Sep; 26(9):835-40. PubMed ID: 2601725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of terminal complement components S-protein and SP-40,40 in renal biopsies.
    Murphy BF; Davies DJ; Morrow W; d'Apice AJ
    Pathology; 1989 Oct; 21(4):275-8. PubMed ID: 2483750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytolytic C5b-9 complement complex: feedback inhibition of complement activation.
    Bhakdi S; Maillet F; Muhly M; Kazatchkine MD
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1912-6. PubMed ID: 3162317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
    Tschopp J; Chonn A; Hertig S; French LE
    J Immunol; 1993 Aug; 151(4):2159-65. PubMed ID: 8345200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of brain clusterin.
    Oda T; Pasinetti GM; Osterburg HH; Anderson C; Johnson SA; Finch CE
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1131-6. PubMed ID: 7980587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SC5b-7, SC5b-8 and SC5b-9 complexes of complement: ultrastructure and localization of the S-protein (vitronectin) within the macromolecules.
    Preissner KP; Podack ER; Müller-Eberhard HJ
    Eur J Immunol; 1989 Jan; 19(1):69-75. PubMed ID: 2465906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminal membrane C5b-9 complex of human complement: transition from an amphiphilic to a hydrophilic state through binding of the S protein from serum.
    Bhakdi S; Tranum-Jensen J
    J Cell Biol; 1982 Sep; 94(3):755-9. PubMed ID: 7130282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of HDL consisting of SP-40,40, apo A-I, and lipids in the formation of SMAC of complement.
    Choi-Miura NH; Sakamoto T; Tobe T; Nakano Y; Tomita M
    J Biochem; 1993 Apr; 113(4):484-7. PubMed ID: 8514737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SP-40,40 immunoreactivity in inflammatory CNS lesions displaying astrocyte/oligodendrocyte interactions.
    Wu E; Brosnan CF; Raine CS
    J Neuropathol Exp Neurol; 1993 Mar; 52(2):129-34. PubMed ID: 8440994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.
    Podack ER; Preissner KT; Müller-Eberhard HJ
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():89-96. PubMed ID: 6587746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH; Abramovitz AS; Mayer MM
    J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reexamination of the role of clusterin as a complement regulator.
    Hochgrebe TT; Humphreys D; Wilson MR; Easterbrook-Smith SB
    Exp Cell Res; 1999 May; 249(1):13-21. PubMed ID: 10328949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.
    Schönermark S; Filsinger S; Berger B; Hänsch GM
    Immunology; 1988 Apr; 63(4):585-90. PubMed ID: 3366469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human seminal clusterin (SP-40,40). Isolation and characterization.
    O'Bryan MK; Baker HW; Saunders JR; Kirszbaum L; Walker ID; Hudson P; Liu DY; Glew MD; d'Apice AJ; Murphy BF
    J Clin Invest; 1990 May; 85(5):1477-86. PubMed ID: 2185274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SP-40,40, a protein involved in the control of the complement pathway, possesses a unique array of disulphide bridges.
    Kirszbaum L; Bozas SE; Walker ID
    FEBS Lett; 1992 Feb; 297(1-2):70-6. PubMed ID: 1551440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SP-40,40 is a constituent of Alzheimer's amyloid.
    Choi-Miura NH; Ihara Y; Fukuchi K; Takeda M; Nakano Y; Tobe T; Tomita M
    Acta Neuropathol; 1992; 83(3):260-4. PubMed ID: 1373021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.